Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Response to pembrolizumab in a patient with primary lung adenocarcinoma originated from indium lung

Fig. 2

a Chest computed tomography in the planes identical to those in Fig. 1 taken 38 days after the video-assisted thoracoscopy; b chest X-ray taken on the day before the first pembrolizumab administration; c enhanced brain magnetic resonance imaging of the sagittal plane shows metastatic brain tumors. The arrowhead in the lower panel indicates the lesion in the right thalamus; d chest X-ray taken on day 30 of pembrolizumab administration; e chest X-ray taken on day 39 of pembrolizumab administration; f chest X-ray taken after 30 cycles of pembrolizumab

Back to article page